2013
DOI: 10.4172/2157-7439.1000172
|View full text |Cite
|
Sign up to set email alerts
|

Rifampicin Nanoprecipitation using Flow Focusing Microfluidic Device

Abstract: We present the nanoprecipitation of rifampicin performed in a microfluidic device as a means to reduce the particle size and enhance the dissolution rate. The microfluidic device was microfabricated in glass substrate with a 45° flow-focusing geometry. The dimensions of the central and side channels are 100 µm and 110 µm in width, respectively, and 85 µm in depth. We analyze the influence of different parameters in the rifampicin particles size, such as: rifampicin concentration, the presence of surfactant, th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 34 publications
2
11
0
Order By: Relevance
“…The optimal formulation consisted of PVP in content of 89.02 mg and solid content of 900 mg was prepared by application of 120 W power input and acid addition with time interval of 15 s. Nearly spherical shape of optimized nanoparticles has been reported for other nanosuspensions. 9,25 Moreover, thermal analysis confirmed partial crystalline state of these particles. Difference in the morphology and crystalline structure of unprocessed cefixime and nanoparticles can affect both pharmaceutical and biopharmaceutical properties such as solubility and dissolution profile of the drug.…”
Section: Discussionmentioning
confidence: 68%
“…The optimal formulation consisted of PVP in content of 89.02 mg and solid content of 900 mg was prepared by application of 120 W power input and acid addition with time interval of 15 s. Nearly spherical shape of optimized nanoparticles has been reported for other nanosuspensions. 9,25 Moreover, thermal analysis confirmed partial crystalline state of these particles. Difference in the morphology and crystalline structure of unprocessed cefixime and nanoparticles can affect both pharmaceutical and biopharmaceutical properties such as solubility and dissolution profile of the drug.…”
Section: Discussionmentioning
confidence: 68%
“…The size of the nanoparticles was significantly smaller and more uniform than that of the respective raw counterparts. The morphology of the particles suggests that the precipitation process inside our microfluidic device was fast, allowing the effective trapping of the drug nanoparticles in a less stable amorphous state [ 9 , 95 , 98 , 101 ]. These results further emphasize the advantage of the use of flow focusing techniques for the synthesis of additive-free nano-drugs of uniform size with enhanced saturation solubility and dissolution rates.…”
Section: Resultsmentioning
confidence: 99%
“…This 3D device is operated in the coaxial flow regimen in order to carry out the nanoprecipitation process [38,39].…”
Section: Fabrication Of Ltcc 3d Microfluidic Reactorsmentioning
confidence: 99%